Kovai Medical Center & Hospital Ltd
₹5,808.45-₹85.75 (-1.5%)
Last close · Data as of Oct 30, 2026
- Market cap
- ₹6,071 Cr
- P/E
- 26.6x
- EV / EBITDA
- 17.2x
- Revenue
- ₹1,371 Cr
- Net margin
- 14.8%
- ROCE
- 28.9%
Price chart
Technical chartScreen technicals →-12.0% over the last year
Daily closes.
Go deeper
Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools
Performance
Price change over each period, before dividends.
- 1M
- -3.4%
- 3M
- -2.4%
- 6M
- +2.5%
- 1Y
- -12.0%
- 5Y
- +250.7%
52-week range
Day change -₹85.75 (-1.5%) from ₹5,894 to ₹5,808 · Last close Oct 30, 2026
Best weekday to invest, historically
The same weekly amount in KOVAI, bought on each weekday since 2021.
AI Summary
Indian StockStrengths1
- Healthy return on equity of 20.2%
Concerns1
- Negative free cash flow (₹259 Cr)
Rule-based from financial data. Not advice.
About the company
Kovai Medical Center and Hospital Limited operates a multi-speciality hospital primarily in India. The company operates in two segments, Healthcare Services and Education Services.
Read moreShow less
Kovai Medical Center and Hospital Limited operates a multi-speciality hospital primarily in India. The company operates in two segments, Healthcare Services and Education Services. It operates various medical facilities, which provide services related to emergency and trauma care, cardiology, oncology, gynaecology and obstetrics, radiology, transplant, neurology, as well as orthopaedics and joint replacement, gastroenterology and haematology, pediatrics, endocrinology, diabetes management, rheumatology, pulmonology, psychiatry, cosmetic surgery, ENT, dermatology, hematology, urology, nephrology, and paediatrics. The company also offers preventive health check-ups and wellbeing programs. In addition, it operates a medical college in Coimbatore. The company serves out-patients, in-patients, and common public. Kovai Medical Center and Hospital Limited was incorporated in 1985 and is based in Coimbatore, India.
- Sector
- Healthcare
- Shares outstanding
- 1.1 Cr shares
- ISIN
- INE177F01017
- BSE code
- 523323
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- ₹6,071 Cr
- P/E
- 26.6x
- P/B
- 5.1x
- EV / EBITDA
- 17.2x
- EV / Sales
- 5.2x
- P/S
- 5.0x
- Earnings yield
- 3.8%
- 52-week high
- ₹6,685.10
- 52-week low
- ₹5,022.65
Profitability
- Operating margin
- 28.4%
- Net margin
- 14.8%
- EBITDA margin
- 30.1%
- ROE
- 20.2%
- ROCE
- 28.9%
- ROA
- 12.5%
- Dividend payout
- 6.0%
- Tax rate
- 24.0%
- Other income, % of PBT
- 8.8%
Growth
- RevenueLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹1,371 Cr
- Revenue growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 12.4%
- Revenue CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 11.4%
- EBITDALatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹367 Cr
- EBITDA growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 27.4%
- Net profit growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 16.1%
- Net profit CAGR, 5YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 13.6%
- Cash from operationsLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- ₹344 Cr
- CFO growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 30.8%
- Free cash flowLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- -₹197 Cr
- Asset growth, 1YLatest stored company figure. It is not dated and can be a year behind the FY2025 statements; the Growth card lists each year.
- 0.0%
Solvency and efficiency
- Current ratio
- 1.18
- Debt / Equity
- 0.35
- Debt / Assets
- 0.22
- Debt / EBITDA
- 0.84
- Interest coverage
- 9.35
- Financial leverage
- 1.62
- CFO / Net profit
- 1.91
- Cash / Market cap
- 4.6%
- Cash per share
- ₹257.80
- Asset turnover
- 0.85
- Fixed asset turnover
- 1.09
- Capital intensity
- 0.92
- Debtor days
- 5 days
- Inventory turnover
- 21.47
- Cash conversion cycle
- -7 days
Where the revenue went
Of every ₹100 of FY2025 revenue, ₹15 was left as net profit.
| From | To | Amount |
|---|---|---|
| Sales | Expenses | ₹981 Cr |
| Sales | Operating profit | ₹390 Cr |
| Operating profit | Interest | ₹36 Cr |
| Operating profit | Depreciation | ₹98 Cr |
| Operating profit | Profit before tax | ₹256 Cr |
| Other income | Profit before tax | ₹21 Cr |
| Profit before tax | Tax and other | ₹69 Cr |
| Profit before tax | Net profit | ₹209 Cr |
Revenue and net profit
Revenue grew 12.4% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2021 | ₹690 Cr | ₹78 Cr |
| FY2022 | ₹905 Cr | ₹104 Cr |
| FY2023 | ₹1,020 Cr | ₹116 Cr |
| FY2024 | ₹1,220 Cr | ₹180 Cr |
| FY2025 | ₹1,371 Cr | ₹209 Cr |
Cash flows
FY2025: ₹353 Cr from operations, -₹259 Cr free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2021 | ₹186 Cr | ₹6 Cr |
| FY2022 | ₹262 Cr | -₹30 Cr |
| FY2023 | ₹263 Cr | -₹95 Cr |
| FY2024 | ₹344 Cr | ₹54 Cr |
| FY2025 | ₹353 Cr | -₹259 Cr |
Growth
Latest fiscal year FY2025 (ending March): each figure with its change over the year before.
- Revenue
- ₹1,371 Cr+12.4%1Y
- Net profit
- ₹209 Cr+16.1%1Y
- Cash from operations
- ₹353 Cr
- Free cash flow
- -₹259 Cr-579.6%1Y
- Revenue CAGR, 5Y
- 11.4%
- EBITDA CAGR, 5Y
- 15.2%
- Net profit CAGR, 5Y
- 13.6%
| Year | Revenue | Operating income | EBITDA | Net profit | CFO | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | ₹1,371 Cr | ₹390 Cr | — | ₹209 Cr | ₹353 Cr | -₹259 Cr | 19.2% | +12.4% | +16.1% |
Monthly returns
Month-by-month returns of KOVAI across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Liabilities and equity | ₹1,801 Cr |
| Equity capital | ₹11 Cr |
| Reserves | ₹1,075 Cr |
| Borrowings | ₹415 Cr |
| Other liabilities | ₹299 Cr |
| Assets | ₹1,801 Cr |
| Fixed assets | ₹1,283 Cr |
| Capital work in progress | ₹154 Cr |
| Investments | ₹0 Cr |
| Other assets | ₹364 Cr |
Market cap against peers
8 peers: same sector group, nearest by size.
P/E against peers
KOVAI trades at 26.6x earnings against a peer median of 52.6x (a 49% discount).
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Kovai Medical Center & Hospital LtdKOVAIthis companyP/E ↓ discount | ₹6,071 Cr | 26.6x | 5.1x | 20.2% | 17.2x |
| Akums Drugs and Pharmaceuticals LimitedAKUMS | ₹6,983 Cr | 50.9x | 2.9x | -114.6% | -133.2x |
| Aarti Pharmalabs LimitedAARTIPHARM | ₹6,923 Cr | 28.3x | 3.6x | 12.4% | 19.5x |
| PARK MEDI WORLD LIMITEDPARKHOSPS | ₹6,504 Cr | 906.0x | — | 7.0% | 214.8x |
| FDC Ltd.FDC | ₹6,387 Cr | 27.0x | 2.6x | 14.6% | 14.2x |
| YATHARTH HOSPITAL & TRAUMA CARE SERVICES LIMITEDYATHARTH | ₹6,186 Cr | 67.3x | 3.9x | 10.0% | 45.5x |
| Supriya Lifescience LimitedSUPRIYA | ₹5,938 Cr | 32.6x | 5.5x | 14.6% | 31.4x |
| Shilpa Medicare Ltd.SHILPAMED | ₹5,771 Cr | 52.6x | 2.2x | 1.3% | 53.7x |
| Entero Healthcare Solutions LimitedENTERO | ₹5,316 Cr | 124.0x | 3.2x | 2.3% | 89.2x |
| Peer median | — | 52.6x | 5.9x | 12.1% | 38.3x |
Year-to-date ROI
KOVAI since 1 January, against earlier years.
Historical volatility
KOVAI's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.
Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2021 | 28.0% |
| FY2022 | 29.0% |
| FY2023 | 27.0% |
| FY2024 | 28.0% |
| FY2025 | 28.0% |
| Line | FY2025 |
|---|---|
| RevenueSales | ₹1,371 Cr |
| Costs | |
| Interest | ₹36 Cr |
| Expenses | ₹981 Cr |
| Operating profitOperating Profit | ₹390 Cr |
| Other income and charges | |
| Profit before tax | ₹278 Cr |
| Tax | |
| Net profitNet Profit | ₹209 Cr |
| Per share |
| Line | FY2025 |
|---|---|
| Liabilities and equityTotal Liabilities | ₹1,801 Cr |
| Equity capitalEquity Capital | ₹11 Cr |
| Reserves | ₹1,075 Cr |
| Borrowings | ₹415 Cr |
| Other liabilitiesOther Liabilities | ₹299 Cr |
| AssetsTotal Assets | ₹1,801 Cr |
| Fixed assetsFixed Assets | ₹1,283 Cr |
| Capital work in progressCWIP | ₹154 Cr |
| Investments | ₹0 Cr |
| Other assetsOther Assets | ₹364 Cr |
| Line | FY2025 |
|---|---|
| Operating cash flowCash from Operating Activity | ₹353 Cr |
| Investing cash flowCash from Investing Activity | -₹612 Cr |
| Financing cash flowCash from Financing Activity | ₹62 Cr |
| Change in cashNet Cash Flow | -₹197 Cr |
Learn while you research
Academy chapters picked for Kovai Medical Center & Hospital Ltd and the metrics on this page.
- 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
- 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 03 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
- 04 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
- 05 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 06 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read